HRH1 and bone sarcoma: Treatment of OS is challenging and new approaches are urgently needed.26 Here, we used a unique approach to sensitize bone sarcomas such as OS cells to hyperthermia, in the presence of the histamine H1 receptor antagonist clemastine.